Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.
Dohlman CH, Cade F, Regatieri CV, Zhou C, Lei F, Crnej A, Harissi-Dagher M, Robert MC, Papaliodis GN, Chen D, Aquavella JV, Akpek EK, Aldave AJ, Sippel KC, DʼAmico DJ, Dohlman JG, Fagerholm P, Wang L, Shen LQ, González-Andrades M, Chodosh J, Kenyon KR, Foster CS, Pineda R, Melki S, Colby KA, Ciolino JB, Vavvas DG, Kinoshita S, Dana R, Paschalis EI. Dohlman CH, et al. Among authors: chodosh j. Cornea. 2018 Feb;37(2):248-251. doi: 10.1097/ICO.0000000000001438. Cornea. 2018. PMID: 29135604 Free PMC article.
Cost-effectiveness of the Boston keratoprosthesis.
Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH. Ament JD, et al. Among authors: chodosh j. Am J Ophthalmol. 2010 Feb;149(2):221-228.e2. doi: 10.1016/j.ajo.2009.08.027. Epub 2009 Nov 24. Am J Ophthalmol. 2010. PMID: 19939347
Global corneal blindness and the Boston keratoprosthesis type I.
Ament JD, Todani A, Pineda R 2nd, Shen TT, Aldave AJ, Dohlman CH, Chodosh J. Ament JD, et al. Among authors: chodosh j. Am J Ophthalmol. 2010 Apr;149(4):537-9. doi: 10.1016/j.ajo.2009.11.001. Am J Ophthalmol. 2010. PMID: 20346774 No abstract available.
Keratoprosthesis in autoimmune disease.
Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J. Ciralsky J, et al. Among authors: chodosh j. Ocul Immunol Inflamm. 2010 Aug;18(4):275-80. doi: 10.3109/09273941003682300. Ocul Immunol Inflamm. 2010. PMID: 20662659 Review.
Cost effectiveness of the type II Boston keratoprosthesis.
Ament JD, Stryjewski TP, Pujari S, Siddique S, Papaliodis GN, Chodosh J, Dohlman CH. Ament JD, et al. Among authors: chodosh j. Eye (Lond). 2011 Mar;25(3):342-9. doi: 10.1038/eye.2010.197. Epub 2010 Dec 24. Eye (Lond). 2011. PMID: 21183944 Free PMC article.
Titanium back plate for a PMMA keratoprosthesis: clinical outcomes.
Todani A, Ciolino JB, Ament JD, Colby KA, Pineda R, Belin MW, Aquavella JV, Chodosh J, Dohlman CH. Todani A, et al. Among authors: chodosh j. Graefes Arch Clin Exp Ophthalmol. 2011 Oct;249(10):1515-8. doi: 10.1007/s00417-011-1684-y. Epub 2011 Apr 26. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21519940 Free PMC article.
Hydroxyapatite for keratoprosthesis biointegration.
Wang L, Jeong KJ, Chiang HH, Zurakowski D, Behlau I, Chodosh J, Dohlman CH, Langer R, Kohane DS. Wang L, et al. Among authors: chodosh j. Invest Ophthalmol Vis Sci. 2011 Sep 22;52(10):7392-9. doi: 10.1167/iovs.11-7601. Invest Ophthalmol Vis Sci. 2011. PMID: 21849419 Free PMC article.
509 results